학술논문

Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): A randomised, phase 2b, dose-ranging trial

Document Type

Article

Author

Margolis, D.A.; Griffith, S.K.; Clair, M.H.S.; Ford, S.L.; Stancil, B.S.; Bomar, M.M.; Hudson, K.J.; Spreen, W.R.; Brinson, C.C.; Smith, G.H.R.; de Vente, J.; Hagins, D.P.; Eron, J.J.; Stevens, M.C.; Williams, P.E.; Smith, K.Y.

Source

In: The Lancet Infectious Diseases. (The Lancet Infectious Diseases, 1 October 2015, 15(10):1145-1155)

Subject

Language

English

ISSN

14744457
14733099

Online Access

Full Text (ScienceDirect 종량제) Full Text (ScienceDirect) Full Text (Clinical Key) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송